Latest Extracellular matrix Stories
SAN FRANCISCO, Jan. 5, 2015 /PRNewswire/ -- Symic Biomedical announced today that the company has secured $15 million in Series A financing.
New contract broadens access of MatriStem to an additional 100,000 healthcare entities COLUMBIA, Md., March 31, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company
Offers broad range of regenerative therapy solutions COLUMBIA, Md., Feb.
Heart valves calcify over time, and Rice University scientists are beginning to understand why.
The threat from a heart attack doesn't end with the event itself.